Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/16/2003 | WO2002034898A8 Enzyme with peroxidase activity isolated from artichoke (cynara scolymus, l.), process for isolation and purification and applications |
10/16/2003 | WO2002004680A3 Real-time sequence determination |
10/16/2003 | WO2001088148A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
10/16/2003 | WO2001077356A3 Protein kinase stress-related proteins and methods of use in plants |
10/16/2003 | US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof |
10/16/2003 | US20030196216 Modifying resistance of plants to disease and/or pests, by using the caffeic acid O-methyltransferase (OMT) gene to modify lignin biosynthesis in plants |
10/16/2003 | US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site |
10/16/2003 | US20030195338 Concatameric immunoadhesion |
10/16/2003 | US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins |
10/16/2003 | US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030195256 Inhibitors of nitric oxide synthase |
10/16/2003 | US20030195164 Novel ribozyme and its use |
10/16/2003 | US20030195162 Genetic marker for spondyloepimetaphyseal dysplasia |
10/16/2003 | US20030195153 Comprises metalloproteinase (stromelysin) inhibitors |
10/16/2003 | US20030195151 Glucanases; xylanases; endoxylanases; isolated from barley/oats; immunoaffinity chromatography |
10/16/2003 | US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
10/16/2003 | US20030194807 Walk-through mutagenesis |
10/16/2003 | US20030194797 Metalloproteinase ADAM 22 |
10/16/2003 | US20030194796 Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme |
10/16/2003 | US20030194795 Genomic regulation of the biosynthesis of phospholipids. |
10/16/2003 | US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194790 DNA sequences coding for ester-group-cleaving enzymes |
10/16/2003 | US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula |
10/16/2003 | US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
10/16/2003 | US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194763 End selection in directed evolution |
10/16/2003 | US20030194762 Use making a claimed cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods |
10/16/2003 | US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194749 Wortmannin derivatives as probes of cellular proteins and processes |
10/16/2003 | US20030194746 For diagnosis, prognosis, prophylaxis |
10/16/2003 | US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/16/2003 | US20030194736 Methods and compositions for DNA manipulation |
10/16/2003 | US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism |
10/16/2003 | US20030194726 Thermus oshimai nucleic acid polymerases |
10/16/2003 | US20030194469 Process for producing aglycon by using diglycosidase and flavor-improved food containing the aglycon and converting agent to be used in the process |
10/16/2003 | US20030194467 Improving the rheological and/or machineability properties by adding to the dough a combination comprising a hexose oxidase and an emulsifying agent. |
10/16/2003 | US20030194406 P-cadherin as a target for anti-cancer therapy |
10/16/2003 | US20030194399 Preparation of deallergenized proteins and permuteins |
10/16/2003 | US20030194398 Having serine protease inhibitory activity |
10/16/2003 | US20030192236 Accelerated mulching paper degradation process and mulching paper for implementing the process |
10/16/2003 | CA2513149A1 A human ribonucleotide reductase m2 subunit |
10/16/2003 | CA2481837A1 Production process for antibody composition |
10/16/2003 | CA2481764A1 Plants with improved morphogenesis and method of constructing the same |
10/16/2003 | CA2481657A1 Cells of which genome is modified |
10/16/2003 | CA2478983A1 Solid phase methods for polynucleotide production |
10/16/2003 | CA2477421A1 Novel promoter |
10/15/2003 | EP1352977A2 Novel Desulfitobacterium strain for the degradation of chloroalkenes |
10/15/2003 | EP1352970A1 Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabloized per se by ugt1a1 or whose intermediate is metabolized by the enzyme |
10/15/2003 | EP1352968A1 Esterase free enzymes |
10/15/2003 | EP1352966A2 Method for producing L-amino acid |
10/15/2003 | EP1352958A1 Gene disrupted yeast |
10/15/2003 | EP1352956A1 Inhibition of DNA methyltransferase |
10/15/2003 | EP1352084A2 Method for identifying modulators of bace |
10/15/2003 | EP1352080A2 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
10/15/2003 | EP1352078A1 Selectable marker for genetically engineered cells and tissues |
10/15/2003 | EP1352069A2 Nucleic acids that code for oxidosqualene cyclases |
10/15/2003 | EP1352057A2 Lipolytic enzyme variant |
10/15/2003 | EP1352056A2 Polypeptides |
10/15/2003 | EP1352055A1 Map kinase integrin-binding domain |
10/15/2003 | EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase |
10/15/2003 | EP1352050A1 Microbiological method for producing amides |
10/15/2003 | EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems |
10/15/2003 | EP1351986A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
10/15/2003 | EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
10/15/2003 | EP1351980A2 Peptides for activation and inhibition of delta pkc |
10/15/2003 | EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents |
10/15/2003 | EP1203079A4 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
10/15/2003 | EP0874908B1 Nucleic acid molecules from plants encoding enzymes which participate in the starch synthesis |
10/15/2003 | CN1449450A Process for the preparation of a beta-lactam nucleus and the application thereof |
10/15/2003 | CN1449447A Butinol I esterase |
10/15/2003 | CN1449442A Process for producing biopterins |
10/15/2003 | CN1449441A Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
10/15/2003 | CN1449440A Masp-2, a complement-fixing enzyme, and uses for it |
10/15/2003 | CN1448508A Glycosylated worm kinase purified by m-aminobenzoic boric acid affinity chromatography and purifying method thereof |
10/15/2003 | CN1448507A Process for preparing gene recombination humanization Cu, Zn Superoxide dismutase |
10/15/2003 | CN1448506A Mutation penicillin ring enlargement enzyme and process preparing 7-ADCA using same |
10/15/2003 | CN1124347C Method for obtg. 2-amino-4-methylphosphine butanoic acid gene |
10/14/2003 | US6632981 Transgenic plants and tissues with chimeric construction; gene expression control |
10/14/2003 | US6632936 Anticancer agents |
10/14/2003 | US6632930 Generating preferential proteins in eukaryotic cells; obtain cells, transform cells, culture cells, recover protein from cells |
10/14/2003 | US6632673 Mutation results in substitution in gene; genetic engineering |